3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pain
1
Neoplasms
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphedema
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leiomyoma
1
Keratosis, Actinic
1
Hodgkin Disease
1
Dermatitis, Contact
1
Dendritic Cell Sarcoma, Interdigitating
1
Chalazion
1
Carcinoma, Basal Cell
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Breast Cancer Lymphedema
1
Anemia, Refractory, with Excess of Blasts
1
Adenomyosis
1
Interventions
Fentanyl
23
Analgesia
22
Morphine
19
Acupuncture Therapy
18
Zoledronic Acid
15
Oxycodone
14
Acetaminophen
14
Ketamine
13
Radiotherapy
12
Therapeutics
11
Methadone
11
Lidocaine
11
nabiximols
10
Ibandronic Acid
10
Hydromorphone
10
Bupivacaine
10
Surveys and Questionnaires
8
Ropivacaine
8
Psychiatric Rehabilitation
7
Early Intervention, Educational
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Massage
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pain
×
Triamcinolone
×
Clear all
NCT02025023
2020-02-06
CTS
University of Washington
Phase 3
Recruiting
120 enrolled